share_log

BRIEF-MYND Life Sciences Signs Deal To Buy Rights For Use Of Psychedelics To Treat Alzheimer's Disease

BRIEF-MYND Life Sciences Signs Deal To Buy Rights For Use Of Psychedelics To Treat Alzheimer's Disease

Brief-mynd生命科學公司簽署協議購買使用迷幻藥治療阿爾茨海默病的權利
reuters ·  2021/10/27 08:22

Oct 27 (Reuters) - MYND Life Sciences Inc MYND.CD :

路透10月27日電-Mynd Life Science Inc MYND.CD:

* MYND LIFE SCIENCES SIGNS AGREEMENT TO ACQUIRE RIGHTS FOR THE USE OF PSYCHEDELICS TO TREAT ALZHEIMER'S DISEASE AND OTHER DEMENTIAS

*Mynd生命科學簽署協議,獲得使用迷幻劑治療阿爾茨海默病和其他痴呆症的權利

Source text for Eikon: ID:nCNW3R7hJa Further company coverage: MYND.CD

Eikon的源文本:ID:nCNW3R7hJa進一步的公司報道:MYND.CD

((Reuters.Briefs@thomsonreuters.com;))

(Reurs.Briefs@thomsonreurs.com;)

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論